Jason L. Vassy MD, MPH

Published on 5/13/2026

Xu G, Karunamuni R, Dornisch AM, Brunette CA, Danowski ME, Desai H, Dochtermann D, Garraway IP, Hauger RL, Kibel AS, Lynch JA, Pyarajan S, Rose BS, Teerlink CC, Andreassen OA, Dale AM, Donovan JL, Hamdy F, Kachuri L, Lane A, Martin RM, Mills IG, Neal DE, Turner EL, Witte JS, Schleutker J, Pashayan N, Batra J, Nordestgaard BG, Hamilton RJ, Wolk A, Albanes D, Atkins J, Blot WJ, Mucci LA, Nielsen SF, Cussenot O, Berndt SI, Koutros S, Sørensen KD, Cybulski C, Menegaux F, Park JY, MacInnis RJ, Rosenstein BS, Lu YJ, Watya S, Vega A, Kogevinas M, Wiklund F, Plym A, Teixeira MR, Multigner L, Leach RJ, Brenner H, John EM, Kaneva R, Logothetis CJ, Neuhausen SL, Ost P, Razack A, Fowke JH, Gamulin M, Usmani N, Claessens F, Castelao JE, Petrovics G, Parent MÉ, Hu JJ, Zheng W, Kote-Jarai Z, Eeles RA, Maxwell KN, Vassy JL, Seibert TM. Germline polygenic score for prostate cancer aggressiveness. medRxiv. 2026 May 13. PMID: 42145622.

Published on 1/26/2026

Vassy JL, Dornisch AM, Karunamuni R, Gatzen M, Kachulis CJ, Lennon NJ, Brunette CA, Danowski ME, Hauger RL, Garraway IP, Kibel AS, Lee KM, Lynch JA, Maxwell KN, Ratner D, Rose BS, Teerlink CC, Xu GJ, Hofherr SE, Lafferty KA, Larkin K, Malolepsza E, Patterson CJ, Toledo DM, Donovan JL, Hamdy FC, Martin RM, Neal DE, Turner EL, Andreassen OA, Dale AM, Mills IG, Abraham A, Batra J, Clements J, Cussenot O, Cybulski C, Eeles RA, Fowke JH, Grindedal EM, Grönberg H, Hamilton RJ, Lim J, Lu YJ, MacInnis RJ, Maier C, Mucci LA, Multigner L, Neuhausen SL, Nielsen SF, Parent MÉ, Park JY, Petrovics G, Plym A, Razack A, Rosenstein BS, Schleutker J, Sørensen KD, Townsend PA, Travis RC, Vega A, West CML, Wiklund F, Zheng W, Seibert TM. Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study. Nat Cancer. 2026 Feb; 7(2):352-367. PMID: 41588240.

Published on 1/2/2026

Vassy JL, Brunette CA, Yi T, Assimes TL, Christensen KD, Knowles JW, Sturm AC, Sun YV, Alexander N, Cardellino MP, Harrison A, Gerety HL, Pyatt M, Vered R, Wilson PWF, Natarajan P, Whitbourne SB, Gaziano JM, Muralidhar S, Danowski ME. Opportunistic Genomic Screening for Familial Hypercholesterolemia to Improve Low-Density Lipoprotein Cholesterol: A Randomized Clinical Trial. JAMA Netw Open. 2026 Jan 02; 9(1):e2549664. PMID: 41511773.

Published on 10/13/2025

Ratner D, Vassy JL. Clinical translation of polygenic scores for prostate cancer screening. Nat Rev Urol. 2026 Apr; 23(4):256-265. PMID: 41083778.

Published on 10/1/2025

Harris WR, Hernandez MS, Ngo KNH, Fladger A, Brunette CA, Hamarneh SR, Knowles JW, Lebo MS, Vassy JL. Electronic health records-based algorithms to screen for U.S. Centers for Disease Control and Prevention tier 1 genetic diseases: a scoping review. J Am Med Inform Assoc. 2025 Oct 01; 32(10):1629-1637. PMID: 40857647.

Published on 9/15/2025

Crawford TB, Nelson T, Karunamuni R, Desai H, Hausler R, Teerlink C, Carter H, Pagadala MS, Alba PR, DuVall SL, Danowski ME, Brunette CA, Ratner D, Garraway IP, Rose BS, Smith JR, Cooney KA, Vassy JL, Hauger RL, Lynch JA, Seibert TM, Maxwell KN. Association of HOXB13 G84E With Prostate Cancer Among 592,158 Men. J Natl Compr Canc Netw. 2025 Sep 15; 23(10). PMID: 40953603.

Published on 7/23/2025

Manolio TA, Rider R, Bult CJ, Chisholm RL, Deverka PA, Ginsburg GS, Green ED, Jarvik GP, Mensah GA, Narula J, Ramos EM, Relling MV, Roden DM, Rowley R, Abul-Husn NS, Buchanan AH, Chute CG, Del Fiol G, Elhanan G, Haga SB, Hamid R, Horowitz CR, Hulick PJ, James CA, Jeff JM, Korf B, Landry L, McGraw D, McLeod HL, Mendelsohn NJ, Osterman T, Taylor CO, Pritchard D, Rehm HL, Tsosie KS, Vassy JL, Watson K, Wiley K, Williams MS. Advancing the science of genomic learning healthcare systems. Learn Health Syst. 2025 Oct; 9(4):e70027. PMID: 41169653.

Published on 6/3/2025

Chanfreau-Coffinier C, Friede KA, Plomondon ME, Lee KM, Lu Z, Dinatale T, DuVall SL, Vassy JL, Waldo SW, Cleator JH, Maddox TM, Rader DJ, Assimes TL, Damrauer SM, Tsao PS, Chang KM, Voora D, Lynch JA, Giri J, Tuteja S. CYP2C19 Polymorphisms and Clinical Outcomes Following Percutaneous Coronary Intervention in the Million Veteran Program. Clin Pharmacol Ther. 2025 Oct; 118(4):876-884. PMID: 40459439.

Published on 5/24/2025

Thomann LO, Hanson KA, Plomp J, Vassy JL, Sawyer SJ. Veteran participation in the All of Us Research Program: applying an intersectionality lens to evaluate participant diversity. BMC Med Res Methodol. 2025 May 24; 25(1):136. PMID: 40413420.

Published on 3/19/2025

Johannsen AL, Danowski ME, Sitter KE, Preys CL, Gerety HL, Brunette CA, Christensen KD, Gaziano JM, Knowles JW, Muralidhar S, Sturm AC, Sun YV, Whitbourne SB, Yi T, Vassy JL. Primary care providers' perspectives on receiving opportunistic genomic results from a national study: The Million Veteran Program Return Of Actionable Results (MVP-ROAR) Study. Genet Med. 2025 Jun; 27(6):101416. PMID: 40121538.